“…CD9 transfection into Chinese hamster ovary, MHO10, ARH77, and MAC 10 cells, for example, inhibited cell motility (Ikeyama et al 1993, Miyake et al 2000. Many clinical studies have revealed that reduced CD9 expression is associated with a poor prognosis in various cancers, including non-small-cell lung cancers, breast cancers, and colon cancers (Huang et al 1998, Funakoshi et al 2003, Hashida et al 2003. Although originally identified as a surface antigen on a pre-B cell line (Kersey et al 1981), CD9 is also expressed on blastocysts in mice and endometrium epithelial cells in human and cattle (Le Naour et al 2000, Park et al 2000, Xiang & MacLaren 2002.…”